Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Understanding biomarkers of neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding.

Literature DB >> 25742456

Understanding biomarkers of neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding.

Kaj Blennow¹, Henrik Zetterberg².

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2015 PMID： 25742456 DOI： 10.1038/nm.3810

Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440

× No keyword cloud information.

9 in total

1. Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study.

Authors: Jeffrey Randall; Erik Mörtberg; Gail K Provuncher; David R Fournier; David C Duffy; Sten Rubertsson; Kaj Blennow; Henrik Zetterberg; David H Wilson
Journal: Resuscitation Date: 2012-08-09 Impact factor: 5.262

2. Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.

Authors: Hlin Kvartsberg; Flora H Duits; Martin Ingelsson; Niels Andreasen; Annika Öhrfelt; Kerstin Andersson; Gunnar Brinkmalm; Lars Lannfelt; Lennart Minthon; Oskar Hansson; Ulf Andreasson; Charlotte E Teunissen; Philip Scheltens; Wiesje M Van der Flier; Henrik Zetterberg; Erik Portelius; Kaj Blennow
Journal: Alzheimers Dement Date: 2014-12-19 Impact factor: 21.566

Review 3. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Authors: Kaj Blennow; Harald Hampel; Michael Weiner; Henrik Zetterberg
Journal: Nat Rev Neurol Date: 2010-02-16 Impact factor: 42.937

4. A sensitive aβ oligomer assay discriminates Alzheimer's and aged control cerebrospinal fluid.

Authors: Mary J Savage; Juliya Kalinina; Abigail Wolfe; Katherine Tugusheva; Rachel Korn; Tanesha Cash-Mason; Jill W Maxwell; Nathan G Hatcher; Sharie J Haugabook; Guoxin Wu; Bonnie J Howell; John J Renger; Paul J Shughrue; Alexander McCampbell
Journal: J Neurosci Date: 2014-02-19 Impact factor: 6.167

5. New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF.

Authors: Ting Yang; Soyon Hong; Tiernan O'Malley; Reisa A Sperling; Dominic M Walsh; Dennis J Selkoe
Journal: Alzheimers Dement Date: 2013-01-30 Impact factor: 21.566

6. Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease.

Authors: Mikko Hölttä; Oskar Hansson; Ulf Andreasson; Joakim Hertze; Lennart Minthon; Katarina Nägga; Niels Andreasen; Henrik Zetterberg; Kaj Blennow
Journal: PLoS One Date: 2013-06-14 Impact factor: 3.240

7. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations.

Authors: David M Rissin; Cheuk W Kan; Todd G Campbell; Stuart C Howes; David R Fournier; Linan Song; Tomasz Piech; Purvish P Patel; Lei Chang; Andrew J Rivnak; Evan P Ferrell; Jeffrey D Randall; Gail K Provuncher; David R Walt; David C Duffy
Journal: Nat Biotechnol Date: 2010-05-23 Impact factor: 54.908

8. Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease.

Authors: Jere E Meredith; Sethu Sankaranarayanan; Valerie Guss; Anthony J Lanzetti; Flora Berisha; Robert J Neely; J Randall Slemmon; Erik Portelius; Henrik Zetterberg; Kaj Blennow; Holly Soares; Michael Ahlijanian; Charles F Albright
Journal: PLoS One Date: 2013-10-07 Impact factor: 3.240

9. Plasma tau levels in Alzheimer's disease.

Authors: Henrik Zetterberg; David Wilson; Ulf Andreasson; Lennart Minthon; Kaj Blennow; Jeffrey Randall; Oskar Hansson
Journal: Alzheimers Res Ther Date: 2013-03-28 Impact factor: 6.982

9 in total

22 in total

Review 1. HIV/neuroAIDS biomarkers.

Authors: Pejman Rahimian; Johnny J He
Journal: Prog Neurobiol Date: 2016-04-12 Impact factor: 11.685

Review 2. Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers.

Authors: Alexander G Thompson; Elizabeth Gray; Sabrina M Heman-Ackah; Imre Mäger; Kevin Talbot; Samir El Andaloussi; Matthew J Wood; Martin R Turner
Journal: Nat Rev Neurol Date: 2016-05-13 Impact factor: 42.937

Review 3. Nanoplasmonic Sensor Approaches for Sensitive Detection of Disease-Associated Exosomes.

Authors: Pouya Amrollahi; Wenshu Zheng; Chandler Monk; Chen-Zhong Li; Tony Ye Hu
Journal: ACS Appl Bio Mater Date: 2021-08-01

Review 4. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic.

Authors: Harald Hampel; Sid E O'Bryant; José L Molinuevo; Henrik Zetterberg; Colin L Masters; Simone Lista; Steven J Kiddle; Richard Batrla; Kaj Blennow
Journal: Nat Rev Neurol Date: 2018-11 Impact factor: 42.937

Review 5. The past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events.

Authors: Kaj Blennow; Henrik Zetterberg
Journal: Front Neurosci Date: 2015-09-29 Impact factor: 4.677

Review 6. Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease.

Authors: Xi-Lin Wu; Juan Piña-Crespo; Yun-Wu Zhang; Xiao-Chun Chen; Hua-Xi Xu
Journal: Chin Med J (Engl) Date: 2017-12-20 Impact factor: 2.628

7. Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer's Dementia: Findings in Two Cohorts.

Authors: Lih-Fen Lue; Marwan N Sabbagh; Ming-Jang Chiu; Naomi Jing; Noelle L Snyder; Christopher Schmitz; Andre Guerra; Christine M Belden; Ta-Fu Chen; Che-Chuan Yang; Shieh-Yueh Yang; Douglas G Walker; Kewei Chen; Eric M Reiman
Journal: Front Aging Neurosci Date: 2017-07-24 Impact factor: 5.750